Elizabeth H.Z. Thompson

Elizabeth H.Z. Thompson is a declared insider at 3 companies (senior executive); the most frequent names are Horizon Therapeutics Public Ltd Co, IGM Biosciences, Inc. and Acadia Pharmaceuticals Inc. Between 1 July 2021 and 30 July 2026, the trades on record add up to 26 filings.

On the market, this insider has only sold: 9 sales, €2.5M in total. The rest of the record consists of 9 share grants and 5 option exercises. Since January 2026: no purchases and 3 sales on the market.

On 31 July 2026 came the latest disclosure, an option exercise in Acadia Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.